These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10740142)
1. Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension. Lopes AA; Maeda NY; Gonçalves RC; Bydlowski SP Am Heart J; 2000 Apr; 139(4):618-23. PubMed ID: 10740142 [TBL] [Abstract][Full Text] [Related]
2. Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension. Lopes AA; Maeda NY Chest; 1998 Nov; 114(5):1276-82. PubMed ID: 9824001 [TBL] [Abstract][Full Text] [Related]
3. Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension. Lopes AA; Maeda NY; Bydlowski SP Am J Med; 1998 Jul; 105(1):21-6. PubMed ID: 9688017 [TBL] [Abstract][Full Text] [Related]
12. [Effect of tetramethylpyrazine on endothelin, von Willebrand factor and thromboxane A2 during cardiopulmonary bypass in patients of congenital heart disease with pulmonary hypertension]. Huang RJ; Liao CX; Chen DZ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Apr; 23(4):268-71. PubMed ID: 12764908 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of von Willebrand factor in adult patients with congenital heart disease. Ohuchi H; Hayama Y; Miike H; Suzuki D; Nakajima K; Iwasa T; Konagai N; Sakaguchi H; Miyazaki A; Shiraishi I; Kurosaki KI; Nakai M Heart; 2020 Jun; 106(12):910-915. PubMed ID: 32188625 [TBL] [Abstract][Full Text] [Related]
15. Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertension. Caramuru LH; Maeda NY; Bydlowski SP; Lopes AA Clin Appl Thromb Hemost; 2004 Jul; 10(3):217-23. PubMed ID: 15247978 [TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis. Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623 [TBL] [Abstract][Full Text] [Related]
17. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension. Lopes AA; Maeda NY; Aiello VD; Ebaid M; Bydlowski SP Chest; 1993 Nov; 104(5):1455-60. PubMed ID: 8222806 [TBL] [Abstract][Full Text] [Related]
18. Role of plasma asymmetric dimethyl-L-arginine levels in detection of pulmonary hypertension in children with CHD. Farag M; El Amrousy D; El-Serogy H; Zoair A Cardiol Young; 2018 Sep; 28(9):1163-1168. PubMed ID: 29950194 [TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response. Borawski J; Naumnik B; Pawlak K; Mysliwiec M Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]